Foamix Investigational Site # 129 — Yardley, Pennsylvania

Foamix Investigational Site # 129 is a clinical research site located in Yardley, Pennsylvania, United States 19067.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Foamix Investigational Site # 129 has participated in 2 clinical trials.

Therapeutic areas: Papulopustular Rosacea, Facial Papulopustular Rosacea.

Sponsors: Vyne Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Yardley

Browse all research sites in Pennsylvania · View every site in Yardley

• Trustees of the University of Pennsylvania, Penn Cardiac Center at Mercer Bucks
• Cardiology Consultants of Philadelphia
• Yardley Dermatology Associates
• Cardiology Consultants of Philadelphia Yardley
• Research Site
• Novartis Investigative Site
• Jeffry A. Lindenbaum DO, PC
• Synergy Research Site
• Galderma Investigational site (8353)
• St. Mary Medical Center
• Yardley Dermatology

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Foamix Investigational Site # 129?

Foamix Investigational Site # 129 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Foamix Investigational Site # 129 conducted?

Foamix Investigational Site # 129 has 2 clinical trials on record. Their work covers Papulopustular Rosacea, Facial Papulopustular Rosacea.

Is Foamix Investigational Site # 129 accredited by Crixeo Clinical Trials?

Foamix Investigational Site # 129 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Foamix Investigational Site # 129?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.